Adjuvant chemotherapy (AC) with cisplatin + gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder cancer (MIBC) submitted to radical cystectomy (RC). An Italian multicenter randomised phase III trial

5023 Background: Fifty-percent of pts with MIBC develops metastases after RC. The role of AC in muscle invasive bladder cancer is under debate as data from 6 randomised trials, moreover with seriou...